United States v. Cunningham

679 F.3d 355, 88 Fed. R. Serv. 365, 2012 WL 1500180, 2012 U.S. App. LEXIS 8786
Court of Appeals for the Sixth Circuit·Decided May 1, 2012·No. 09-5987, 09-5998·Published·Cited by 97 cases

Opinion

OPINION

RONALD LEE GILMAN, Circuit Judge.

Shirley Cunningham, Jr., and William Gallion were two of three Kentucky lawyers who represented several hundred Kentucky clients in a mass-tort action against the manufacturer of the defective drug “fen-phen.” They settled the case for $200 million, which entitled them under their retainer agreements to approximately $22 million each in attorney fees. But rather than limit themselves to what they had contractually earned, Cunningham and Gallion concocted a fraudulent scheme to take from their clients almost twice that amount. The scheme did not work out as planned: Cunningham and Gallion were caught, subsequently disbarred from practicing law in Kentucky, and indicted on one count of conspiracy to commit wire fraud, in violation of 18 U.S.C. §§ 1343 and 1349.

After a mistrial, a superseding indictment was issued that again charged Cunningham and Gallion with one count of conspiracy to commit wire fraud, but added eight counts that specifically detailed the wire communications that were part of the scheme. The two men were convicted on all counts at their second trial. They have appealed and now attack their convictions on numerous grounds. For the reasons set forth below, we AFFIRM the judgment of the district court.

I. BACKGROUND

A. Factual background

In the 1990s, the diet drug popularly known as “fen-phen” (named for the combination of fenfluramine and phentermine) was used by an estimated six million Americans. Fen-phen was initially hailed as a miracle drug, yet turned out to be anything but when it was found to cause heart-valve dysfunctions in as many as a third of its users. These dysfunctions soon produced injuries, which in turn produced litigation.

One lawsuit in particular marks the factual starting point for this appeal. In 1998, a group of injured fen-phen users in Kentucky, represented by Kentucky lawyers Shirley Cunningham, William Gallion, and Melbourne Mills, brought a prospective class action against American Home Products (AHP), the drug’s manufacturer. Also named as defendants in the lawsuit were Rex Duff, a Kentucky doctor who had prescribed fen-phen to many of the injured plaintiffs, as well as the clinic that Duff owned and operated. The case was certified as a class action in May 1999, but no notice was given to potential class members.

While the lawsuit was pending in Kentucky state court, another case against AHP was proceeding as a federal multidistrict class-action claim in Pennsylvania. The federal litigation eventually resulted in a nationwide class-action settlement in August 2000, which was approved by the Pennsylvania district court supervising the case. Under the terms of the settlement, which defined the class as all persons in the United States who had used fen-phen, the Kentucky plaintiffs would have received a share of the total settlement amount in exchange for releasing their claims against AHP. But on the advice of *364 their lawyers, the Kentucky plaintiffs opted out of the nationwide settlement, preferring instead to take their chances in the state-court action. A total of approximately 431 clients represented by either Cunningham, Gallion, or Mills opted out.

As a tactical move, opting out made financial sense for both the clients and their attorneys. The clients believed (correctly, as it turned out) that they would receive a more generous recovery by pursuing their own action in state court. And if they received such a recovery, their attorneys stood to make huge amounts of money in fees because each attorney had entered into retainer agreements with his respective clients entitling him to roughly a third of each client’s recovery.

Because the state-court action remained quite large and complex — -involving hundreds of plaintiffs with injuries ranging widely in terms of scope and severity — the attorneys sought outside help. They brought in class-action specialist Stanley Chesley, an attorney based in Cincinnati, Ohio. Chesley’s role was to help negotiate a settlement with AHP. If he succeeded in reaching a settlement, the Kentucky attorneys and Chesley agreed that Chesley would receive a share — at first 27 percent, but later reduced to 21 percent — of the attorney fees owed to Cunningham, Gal-lion, and Mills under their respective retainer agreements.

Settlement mediation between the Kentucky plaintiffs and AHP took place in the spring of 2001. According to the trial testimony of Jack Vardaman, who served as counsel for AHP during the settlement-negotiation process, the purpose of the mediation (and thus the purpose of any settlement agreement reached as a result of the mediation) was to settle the claims of the 431 clients represented by Cunningham, Gallion, and Mills; it was not to settle the claims of anyone else who might otherwise have qualified as a member of the class. The 431 clients were nevertheless kept in the dark throughout the settlement-negotiation process. As one internal email that Gallion sent prior to the mediation reads: “We do not want to tell any clients that we are going to try to settle a bunch of cases for a lump sum and then divide up the money. That is only inviting trouble.”

After two days of mediation, AHP and the claimants’ attorneys struck a deal on May 1, 2001. The total amount of the settlement was $200 million. Relevant provisions of the agreement included the following:

• the $200 million would be distributed to and allocated by Cunningham, Gal-lion, and Mills;
• AHP had a right to terminate the settlement agreement as to all claimants unless 95 percent of the claimants accepted the agreement by September 1, 2001;
• any claimant who accepted the settlement agreement would have to sign a release, thereby losing his or her right to bring a future claim against AHP arising out of the use of fen-phen;
• Cunningham, Gallion, and Mills would move to decertify the state-court class action and dismiss the case with prejudice;
• AHP would not pay any of the $200 million unless most of the claimants with the worst injuries agreed to settle their cases;
• all settlement terms were confidential except for the purposes of receiving tax advice or complying with a court order, and any knowing breach of confidentiality would result in Cunningham, Gallion, and/or Mills paying $100,000 in damages to AHP; and
*365 • in a side letter to the agreement, Cunningham, Gallion, and Mills agreed to indemnify AHP up to the amount of $7.5 million for any future claims brought against Duff or his climes within one year of dismissal of the state-court action by individuals who were not included in the settlement agreement.

Cunningham, Gallion, and Mills each signed the agreement. Vardaman signed on behalf of AHP.

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Cunningham, 679 F.3d 355, 88 Fed. R. Serv. 365, 2012 WL 1500180, 2012 U.S. App. LEXIS 8786 (6th Cir. 2012).

679 F.3d 355 (United States v. Cunningham) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related